Aster DM Quality Care (NSE:ASTERDM) 6-Month Price Index: 1.14 (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ASTERDM Aster DM Quality Care Ltd NSE:ASTERDM
77 GF Score
Price ₹748.40
GF Value ₹638.28
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Aster DM Quality Care 6-Month Price Index?

Aster DM Quality Care NSE:ASTERDM -0.85% 77 6-Month Price Index is 1.14 as of Aug. 31, 2026. GuruFocus rates NSE:ASTERDM with a GF Score™ of 77/100 and a GF Value™ of ₹638.28 (Modestly Overvalued). The stock has 3 warning signs investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-08-31), Aster DM Quality Care's 6-Month Price Index is 1.14.

Aster DM Quality Care  (NSE:ASTERDM) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Aster DM Quality Care 6-Month Price Index Related Terms

NSE:ASTERDM vs HCA, THC, EHC: 6-Month Price Index Comparison

For the Medical Care Facilities subindustry, Aster DM Quality Care's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NSE:ASTERDM
77GF Score
Aster DM Quality Care Ltd NSE:ASTERDM
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aster DM Quality Care  (NSE:ASTERDM) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 1.14 mean?
Aster DM Quality Care (NSE:ASTERDM) has a 6-Month Price Index of 1.14 as of Aug. 31, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Aster DM Quality Care and its competitors.
Is Aster DM Quality Care's 6-Month Price Index too high?
Aster DM Quality Care's current 6-Month Price Index is 1.14. Overall, Aster DM Quality Care has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aster DM Quality Care's 6-Month Price Index compare to HCA and THC?
Aster DM Quality Care's 6-Month Price Index of 1.14 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Healthcare Providers & Services company?
A good 6-Month Price Index depends on the Healthcare Providers & Services industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Aster DM Quality Care and its competitors. Aster DM Quality Care's current 6-Month Price Index is 1.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aster DM Quality Care stock overvalued right now?
Based on GuruFocus' analysis, Aster DM Quality Care (NSE:ASTERDM) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹638.28, compared to a current price of ₹748.40 — trading 17.3% above its estimated fair value. The current 6-Month Price Index is 1.14. Aster DM Quality Care's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For Aster DM Quality Care (NSE:ASTERDM), the current 6-Month Price Index is 1.14 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aster DM Quality Care (NSE:ASTERDM) Overvalued in 2026?

Based on GuruFocus' analysis, Aster DM Quality Care stock appears to be overvalued. The current stock price of ₹748.40 is trading 17.3% above its estimated GF Value™ of ₹638.28. GuruFocus considers Aster DM Quality Care to be Modestly Overvalued.

Key valuation signals for NSE:ASTERDM:

  • 6-Month Price Index: 1.14
  • GF Value™: ₹638.28 vs. price of ₹748.40 (17.3% above fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the NSE:ASTERDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aster DM Quality Care Business Description

Other Exchanges 540975:India
Address 27 and 27/1, Mission Road, Awfis, 2nd Floor, Renaissance Centra, Sampangirama Nagar, Bengaluru, KA, IND, 560027
Aster DM Healthcare Ltd is an India-based integrated healthcare provider. The group operates a comprehensive healthcare network comprising approximately 19 hospitals, 10 clinics, over 200 pharmacies, and more than 255 diagnostic laboratories across states. Its business segments include Hospitals, Clinics, Retail Pharmacies, and Others, with the majority of revenue derived from the Hospitals segment. Aster has been delivering high-quality care from primary to quaternary through dedicated personnel across clinical and non-clinical roles. Aster has a presence in metropolitan as well as Tier II and Tier III cities, and is committed to providing advanced and accessible healthcare in line with global standards, guided by a patient-first approach.
77GF Score

Get the complete analysis for NSE:ASTERDM

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹748.40
Price
₹638.28
GF Value